Zoetis (ZTS)
(Delayed Data from NYSE)
$176.96 USD
+0.25 (0.14%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $176.98 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
ZTS 176.96 +0.25(0.14%)
Will ZTS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZTS
SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zoetis Q3 Earnings & Revenues Beat, '24 Outlook Raised, Stock Up
Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics
Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates
Other News for ZTS
Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
Quality cyclicals are expected to continue going up, here are the top-rated by Morgan Stanley
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
Zoetis Announces Major Leadership Changes for Growth
Piper Sandler Issues a Buy Rating on Zoetis (ZTS)